ESC 2021

2021-08-27 - 2021-08-30
Online, Virtual

ACC 2021

2021-05-15 - 2021-05-17
Online, Virtual

ESH-ISH 2021

2021-04-11 - 2021-04-14
Online, Virtual

AHA 2020

2020-11-13 - 2020-11-17
Online, Virtual

ESC 2020

2020-08-29 - 2020-09-01
Online, Virtual

ESH 2020

2020-05-29 - 2020-06-01
Online, Virtual

ESC 2019

2019-08-31 - 2019-09-04
Paris, France

ACC 2019

2019-03-17 - 2019-03-19
New Orleans, LA, United States
Search in Scientific Content:
Date
Filters:
SSaSS: Sal
3:42

SSaSS: Salt Substitute and Stroke Study into the effect of salt substitutes on cardiovascular events and death

Presenter: Bruce Neal
ESC 2021
2021 ESC G
7:39

2021 ESC Guidelines - CVD Prevention

Presenter: Frank Visseren
ESC 2021
The curren
16:03

The current management of Angina

Presenter: Mario Marzilli
ESC 2021
LOOP Study
9:21

LOOP Study: screening for AF with an implantable loop recorder to prevent stroke

Presenter: Jesper Hastrup Svendsen
ESC 2021
TOMAHAWK:
3:45

TOMAHAWK: immediate angiography after out-of-hospital cardiac arrest

Presenter: Steffen Desch
ESC 2021
ENVISAGE-T
14:52

ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation

Presenter: George Dangas
ESC 2021
2021 ESC G
5:23

2021 ESC Guidelines - Cardiac Pacing

Presenter: Michael Glikson
ESC 2021
The STEP S
4:20

The STEP Study

Presenter: Diederick E. Grobbee
ESC 2021
The new ad
12:00

The new advancements in angina

Presenter: Luis Henrique Gowdak
ESC 2021
The RIPCOR
6:43

The RIPCORD 2 trial

Presenter: Nicholas Curzen
ESC 2021
The EMPERO
9:06

The EMPEROR-Preserved Trial

Presenter: Stefan D. Anker
ESC 2021
The SMART-
7:08

The SMART-MI Trial

Presenter: Axel Bauer
ESC 2021
2021 ESC G
11:56

2021 ESC Guidelines - Heart Failure

Presenter: Marco Metra
ESC 2021
What is ne
4:23

What is new about Angina?

Presenter: Piotr Jankowski
ESC 2021
2021 ESC G
5:32

2021 ESC Guidelines - Cardiac Pacing

Presenter: Jens Cosedis Nielsen
ESC 2021
The APAF-C
7:49

The APAF-CRT Trial

Presenter: Michele Brignole
ESC 2021
CLARIFY -
7:07

CLARIFY - In stable coronary disease, patients with angina and prior myocardial infarction have a poor prognosis despite adherence to guideline recommanded therapies. Final 5-year results from the CLARIFY study

Presenter: Emmanuel Sorbets
SWEDEHEART
5:26

SWEDEHEART: Secondary prevention medication after coronary artery bypass surgery and long-term mortality: A longitudinal population-based study from the SWEDEHEART registry

Presenter: Erik Bjoerklund
ICD use in
4:31

ICD use in HF - Association between implantable cardioverter-defibrillator use for primary prevention and mortality: a prospective propensity-score matched study

Presenter: Benedikt Schrange
PURE: Impa
10:51

PURE: Impact of modifiable risk factors on cardiovascular disease and mortality

Presenter: Salim Yusuf
RAPIDTnT:
5:37

RAPIDTnT: A randomised trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: the Rapid Assessment of Possible ACS In the emergency Department with high sensitivity Troponin T

Presenter: Derek Chew
ENTRUST-AF
7:45

ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting in atrial fibrillation patients.

Presenter: Andreas Goette
POPular Ge
6:51

POPular Genetics - Genotype-guided oral P2Y12-inhibition in patients with St-segment elevation myocardial infarction undergoing primary PCI : a randomized, open-label, multicenter trial

Presenter: Jurrien M. Ten Berg
Combined e
5:03

Combined effect of lower LDL-C and lower SBP on the lifetime risk od cardiovascular disease

Presenter: Brian A. Ference
AFIRE - Ri
4:47

AFIRE - Rivaroxaban monotherapy versus dual therapy in patients with atrial fibrillation and stable coronary artery disease

Presenter: Satoshi Yasuda
GALACTIC -
7:23

GALACTIC - Goal-directed AfterLoad Reduction in Acute Congestive Cardiac Decompensation: a randomized controlled trial

Presenter: Christian Eugen Mueller
Salt subst
5:16

Salt substitution and community-wide reduction in blood pressure and hypertension incidence

Presenter: J. Jaime Miranda
HOPE 4 - I
5:19

HOPE 4 - Impact on cardiovascular risk of a community based multifaceted intervention in individuals with hypertension in 2 middle income countries: The Heart Outcomes Prevention and Evaluation 4 study

Presenter: J.D. Schwalm
SYNTAXES:
7:28

SYNTAXES: Ten-Year Survival after Coronary Artery Bypass Grafting versus Percutaneous Coronary Intervention: The SYNTAX Extended Survival study

Presenter: Daniel Johannes Franciscus Maria Thuijs
MITRA-FR -
8:46

MITRA-FR - 2 years follow-Up of the MITRA-FR study a randomized controlled trial evaluating the effectiveness of percutaneous mitral valve repair in secondary mitral regurgitation

Presenter: Jean-Francois Obadia
DAPA HF Th
6:20

DAPA HF The Dapagliflozin And Prevention Of Adverse-outcomes In Heart Failure Trial

Presenter: John McMurray
CONDI-2/ER
4:010

CONDI-2/ERIC-PPCI Effect of remote ischemic conditioning on clinical outcomes in patients with Stsegment elevation myocardial infarction undergoing primary percutaneous coronary intervention

Presenter: Hans Erik Botker